Academic literature on the topic 'Trials'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Trials.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Trials"
Seow, Hsien-Yeang, Patrick Whelan, Mark N. Levine, Kathryn Cowan, Barbara Lysakowski, Brenda Kowaleski, Anne Snider, Rebecca Y. Xu, and Andrew Arnold. "Funding Oncology Clinical Trials: Are Cooperative Group Trials Sustainable?" Journal of Clinical Oncology 30, no. 13 (May 1, 2012): 1456–61. http://dx.doi.org/10.1200/jco.2011.37.2698.
Full textVan Der Weyden, Martin B. "Trials on trial." Medical Journal of Australia 175, no. 5 (September 2001): 241. http://dx.doi.org/10.5694/j.1326-5377.2001.tb143553.x.
Full textNelson, Mark. "Trials on trial." New Scientist 209, no. 2800 (February 2011): 30. http://dx.doi.org/10.1016/s0262-4079(11)60384-9.
Full textVulto, Arnold G. "Clinical trials on trial." European Journal of Hospital Pharmacy 19, no. 4 (August 2012): 347. http://dx.doi.org/10.1136/ejhpharm-2012-000180.
Full textPimentel, Leonardo Duarte, Claudio Horst Bruckner, Candida Elisa Manfio, Sérgio Yoshimitsu Motoike, and Hermínia Emília Prieto Martinez. "SUBSTRATE, LIME, PHOSPHORUS AND TOPDRESS FERTILIZATION IN MACAW PALM SEEDLING PRODUCTION." Revista Árvore 40, no. 2 (April 2016): 235–44. http://dx.doi.org/10.1590/0100-67622016000200006.
Full textde Vries, Ymkje Anna, Annelieke M. Roest, Erick H. Turner, and Peter de Jonge. "Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials." Psychological Medicine 49, no. 12 (September 28, 2018): 2020–26. http://dx.doi.org/10.1017/s0033291718002805.
Full textKim, Daniel J., Dan Otap, Nora Ruel, Naveen Gupta, Naveed Khan, and Tanya Dorff. "NCI–Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center." Journal of Clinical Medicine 9, no. 6 (June 24, 2020): 1970. http://dx.doi.org/10.3390/jcm9061970.
Full textFoster, Henry H. "TRIAL MARRIAGES AND DIVORCE TRIALS." Family Court Review 11, no. 1 (March 15, 2005): 1–7. http://dx.doi.org/10.1111/j.174-1617.1973.tb01183.x.
Full textHarman, Chloë. "Putting clinical trials on trial." Nature Reviews Nephrology 5, no. 6 (June 2009): 301. http://dx.doi.org/10.1038/nrneph.2009.89.
Full textMIZUSHIMA, YUTAKA. "New trials of trial cases." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 29, no. 1/2 (1998): 1–6. http://dx.doi.org/10.3999/jscpt.29.1.
Full textDissertations / Theses on the topic "Trials"
Kim, Anne(Anne Y. ). "Optimizing clinical trials with Open Trial Chain." Thesis, Massachusetts Institute of Technology, 2018. https://hdl.handle.net/1721.1/121787.
Full textCataloged from student-submitted PDF version of thesis.
Includes bibliographical references (pages 59-64).
The objective of this thesis is to study the challenges of data sharing in healthcare (namely clinical trials), and propose the use of Open Algorithms (OPAL) as a viable solution for research collaboration that allows for access to data without compromising data ownership (data is only used once for the intended purpose, raw data is never leaked, the value generated from the data is transferred to the owner). This thesis surveys the challenges unique to clinical trials, and highlights the various methods for privacy-preserving computation prior to this work. Through the overview of OPAL's solution in the space of privacy-preserving computation, we show the implementation details of how OPAL was applied to clinical trials in a project called Open Trial Chain, a platform for clinical trial data built for analytics, security, and incentivized sharing through technologies like federated learning and blockchain. With motivated examples derived from real-world reported problems in healthcare, we also demonstrate speed, accuracy, and security metrics. In the application, Open Trial Chain can drastically reduce clinical trial costs, reduce error, and increase quality of analysis diversity. Overall, this project shows promise for further extension in other health datasets for compliance in an ever-complicated move towards regulations that reflect for conscientiousness for data security, ownership, and provenance.
by Anne Kim.
M. Eng.
M.Eng. Massachusetts Institute of Technology, Department of Electrical Engineering and Computer Science
Richert, Laura. "Trial design and analysis of endpoints in HIV vaccine trials." Thesis, Bordeaux 2, 2013. http://www.theses.fr/2013BOR22048/document.
Full textComplex data are frequently recored in recent clinical trials and require the use of appropriate statistical methods. HIV vaccine research is an example of a domaine with complex data and a lack of validated endpoints for early-stage clinical trials. This thesis concerns methodological research with regards to the design and analysis aspects of HIV vaccine trials, in particular the definition of immunogenicity endpoints and phase I-II trial designs. Using cytokine multiplex data, we illustrate the methodological aspects specific to a given assay technique. We then propose endpoint definitions and statistical methods appropriate for the analysis of multidimensional immunogenicity data. We show in particular the value of non-parametric multivariate scores, which allow for summarizing information across different immunogenicity markers and for making statistical comparisons between and within groups. In the aim of contributing to the design of new vaccine trials, we present the construction of an optimized early-stage HIV vaccine design. Combining phase I and II assessments, the proposed design allows for accelerating the clinical development of several vaccine strategies in parallel. The integration of a stopping rule is proposed from both a frequentist and a Bayesian perspective. The methods advocated in this thesis are transposable to other research domains with complex data, such as imaging data or trials of other immune therapies
Cuevas, Arriagada Ricardo Enrique, and Bustos Neil William Páez. "B-TRIALS." Tesis, Universidad de Chile, 2017. http://repositorio.uchile.cl/handle/2250/146375.
Full textRicardo Enrique Cuevas Arriagada [Parte I], Neil William Páez Bustos [Parte II]
El presente trabajo desarrolla una idea de negocio llamada B-Trials, cuyo origen surge a partir de una necesidad específica en la ejecución de Estudios Clínicos de la Industria Farmacéutica local, que corresponde al aumento en la participación de pacientes en la ejecución de los protocolos de estudios, a modo de aumentar la competitividad frente a los otros países de la región. Actualmente, son los médicos tratantes, colegas y/o contactos de los mismos quienes derivan pacientes a los Estudios Clínicos, por lo que este proyecto plantea la creación de una nueva forma de captación de pacientes e implementar una nueva forma de derivación de pacientes, con el fin de revolucionar a este mercado de USD $30 MM anuales. Gracias a la fluidez de los procesos regulatorios y obtención de resultados requeridos por las compañías farmacéuticas, es que Chile se hace atractivo, sopesando la menor cantidad de pacientes que puede ofrecer a diferencia de países como Argentina, Brasil, Colombia y México. Dado que desde los inicios de la Investigación Clínica en Chile se ha utilizado el mismo sistema de derivación de pacientes, B-Trials toma esta oportunidad y captará pacientes en el mundo de las Redes Sociales, que cada vez son más utilizadas por la sociedad, los que serán registrados en una página web y se construirá una base de datos propia. La base de datos permitirá identificar a distintos pacientes dispuestos a participar en los Estudios Clínicos, de acuerdo a parámetros clínicos específicos y zonas geográficas donde se encuentran, permitiendo la derivación de estos a Centros de Estudios ya operativos y dando la opción de tener la información necesaria para la instalación de un Centro de Estudios Clínicos propio en la ubicación con mayor demanda de pacientes y abastecerlo de pacientes. El equipo gestor está encargados del marketing, operaciones y comercial, áreas cruciales para la obtención de la ventaja competitiva. El proyecto B-Trials requiere de una Inversión Inicial de CLP $67 MM., con Payback de 3,5 años, TIR = 31% y VAN al año 5 de CLP $ 23 MM. Valor Residual = $ 403 MM. Tasa de descuento aplicada = 20,4%. B-Trials representa un negocio que satisface una necesidad de la Industria en forma innovadora, siendo pionero en el país y escalable en el territorio nacional y latinoamericano, mejorando la calidad de vida de los pacientes a través del acceso gratuito a tratamientos de última generación.
Dias, Claire Rhiannon. "Olympic trials." Thesis, Bangor University, 2014. https://research.bangor.ac.uk/portal/en/theses/olympic-trials(feb17a88-72fb-4577-9369-810a7420399e).html.
Full textLoudon, Kirstine. "PRECIS-2 : making trials matter : providing an empirical basis for the selection of pragmatic design choices in clinical trials." Thesis, University of Dundee, 2015. https://discovery.dundee.ac.uk/en/studentTheses/af271d88-4652-41e0-b280-4772cc30f8c4.
Full textCarvajal, Luis A. Rodriguez. "Multivariate crossover trials." Thesis, University of Warwick, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336783.
Full textKopec, David M., and Jeffrey J. Gilbert. "Overseeding Fairway Trials." College of Agriculture and Life Sciences, University of Arizona (Tucson, AZ), 2001. http://hdl.handle.net/10150/216378.
Full textBartoszuk, Karin. "Randomized Control Trials." Digital Commons @ East Tennessee State University, 2017. https://dc.etsu.edu/etsu-works/4161.
Full textJulian, Robert F. "The role of the judge and jury in complex trials." Thesis, Queen Mary, University of London, 2008. http://qmro.qmul.ac.uk/xmlui/handle/123456789/28172.
Full textCaldwell, Patrina Ha Yuen. "The Recruitment of Children to Randomised Controlled Trials." University of Sydney. Paediatrics and Child Health, 2003. http://hdl.handle.net/2123/579.
Full textBooks on the topic "Trials"
Trial techniques and trials. New York: Wolters Kluwer Law & Business, 2013.
Find full textMichael, Phillips, Bergman Barbara, and Oregon Criminal Defense Lawyers Association., eds. Trials and tribulations: (overcoming trial problems). Eugene, Or: [Oregon Criminal Defense Lawyers Association], 1999.
Find full textTrials. New York, N.Y., U.S.A: Dutton, 1996.
Find full textMerrill, Umphrey Martha, ed. Trials. Aldershot, England: Ashgate, 2008.
Find full textRafael, Nieves, Hayden Seitu, and Baroza Aldin, eds. Trials. San Jose, CA: SLG Pub., 1996.
Find full textWallach, Anne Tolstoi. Trials. New York, N.Y., U.S.A: Dutton, 1996.
Find full textMerrill, Umphrey Martha, ed. Trials. Aldershot, England: Ashgate, 2008.
Find full textMaxine, Caron, and Williams Wyn, eds. Schools on trial: The trials of democratic comprehensives. Milton Keynes, England: Open University Press, 1985.
Find full textFletcher, Colin. Schools on trial: The trials of democratic comprehensives. Milton Keynes: Open University Press, 1985.
Find full textKlonoff, Robert H. Winning jury trials: Trial tactics and sponsorship strategies. 3rd ed. Louisville, Colo: National Institute for Trial Advocacy, 2007.
Find full textBook chapters on the topic "Trials"
Patra, Jayanta Kumar, Swagat Kumar Das, Gitishree Das, and Hrudayanath Thatoi. "Clinical Trials." In A Practical Guide to Pharmacological Biotechnology, 109–26. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-6355-9_6.
Full textBasu, Bikramjit, and Sourabh Ghosh. "Clinical Trials." In Biomaterials for Musculoskeletal Regeneration, 191–216. Singapore: Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-3017-8_9.
Full textBlacher, Lynette, and Linda Marillo. "International Trials." In Principles and Practice of Clinical Trials, 1–22. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-52677-5_44-1.
Full textProrok, Philip C. "Screening Trials." In Principles and Practice of Clinical Trials, 1–19. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-52677-5_95-1.
Full textMcKneally, M. F., B. McPeek, F. Mosteller, and E. A. M. Neugebauer. "Clinical Trials." In Surgical Research, 197–209. New York, NY: Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4612-1888-3_26.
Full textRhoads, Kim F., and Julio E. Garcia-Aguilar. "Clinical Trials." In Transanal Endoscopic Microsurgery, 125–33. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-76397-2_13.
Full textStaquet, M. "Clinical Trials." In Surgical Oncology, 446–50. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-72646-0_43.
Full textFriedman, Lawrence M., Curt D. Furberg, and David L. DeMets. "Multicenter Trials." In Fundamentals of Clinical Trials, 427–40. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1586-3_20.
Full textChen, Donna T. "Clinical Trials." In Encyclopedia of Women’s Health, 271–73. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-0-306-48113-0_91.
Full textCheng, Zhaoqi. "The Trials." In A History of War Crimes Trials in Post 1945 Asia-Pacific, 71–103. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-6697-0_3.
Full textConference papers on the topic "Trials"
Stubberfield, J. "ADSL trials." In IEE Seminar How Big is Your Pipe? Fast SoHo SME/Connectivity. IEE, 1999. http://dx.doi.org/10.1049/ic:19990322.
Full textKennedy, J., N. Sponagle, D. Wheaton, P. MacDonald, and R. Creaser. "Video Systems For Propeller Viewing Trials." In SNAME 22nd American Towing Tank Conference. SNAME, 1989. http://dx.doi.org/10.5957/attc-1989-024.
Full textRelton, Clare. "Randomised Controlled Trials." In HRI London 2019—Cutting Edge Research in Homeopathy: Presentation Abstracts. The Faculty of Homeopathy, 2020. http://dx.doi.org/10.1055/s-0040-1702078.
Full textAnderson, James, Sarah Watts, Nigel Hills, and Emmanuel Ofosu-Apeasah. "Submarine Towing Trials." In Warship 2005: Naval Submarines 8. RINA, 2005. http://dx.doi.org/10.3940/rina.ws.2005.17.
Full textThatcher, K. C., B. Grant, and S. E. Welford. "RNLI Anchor Trials." In Surveillance, Pilot and Rescue Craft For The 21st Century. RINA, 1990. http://dx.doi.org/10.3940/rina.sur.1990.3.2.
Full textMartin, John R. "RISTA II trials." In SPIE's International Symposium on Optical Science, Engineering, and Instrumentation, edited by Wallace G. Fishell, Arthur A. Andraitis, Michael S. Fagan, Jerry D. Greer, and Mark C. Norton. SPIE, 1998. http://dx.doi.org/10.1117/12.330204.
Full textRodriguez, M. B., P. Plaza, and M. Ibanez. "ePerSpace Intemediate Trials." In International conference on Networking and Services (ICNS'06). IEEE, 2006. http://dx.doi.org/10.1109/icns.2006.46.
Full textHilsenbeck, S., and M. Piccart. "Clinical Trials 102: New Strategies in Targeted Therapy Clinical Trials." In Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-es5-1.
Full textPile, J. H. "Color Line “Superspeed 1” Trials 2009. The 1st Safeguard Trials." In Safeguard Passenger Evacuation Seminar. RINA, 2012. http://dx.doi.org/10.3940/rina.safe.2012.01.
Full textLetourneau, J. E. "Effect of the warning signal on visual reaction time during recovery from general anesthesia." In OSA Annual Meeting. Washington, D.C.: Optica Publishing Group, 1990. http://dx.doi.org/10.1364/oam.1990.tuy25.
Full textReports on the topic "Trials"
Kaplan, Celia P. Minorities in Clinical Trials: Patients, Physicians, Clinical Trial Characteristics, and Their Environment. Fort Belvoir, VA: Defense Technical Information Center, July 2010. http://dx.doi.org/10.21236/ada542448.
Full textKaplan, Celia. Minorities and Clinical Trials: Patients, Physicians, Clinical Trial Characteristics, and Their Environment. Fort Belvoir, VA: Defense Technical Information Center, July 2011. http://dx.doi.org/10.21236/ada573587.
Full textKaplan, Celia P. Minorities and Clinical Trials: Patients, Physicians, Clinical Trial Characteristics and their Environment. Fort Belvoir, VA: Defense Technical Information Center, July 2012. http://dx.doi.org/10.21236/ada586285.
Full textNelson, Eric. First Trials with EMPHASIS. Office of Scientific and Technical Information (OSTI), September 2020. http://dx.doi.org/10.2172/1660566.
Full textFawcett, Jim, Zack Koopman, Wayne Roush, and Josh Sievers. On-Farm Corn Rootworm Trials. Ames: Iowa State University, Digital Repository, 2015. http://dx.doi.org/10.31274/farmprogressreports-180814-1053.
Full textFawcett, Jim, Lance Miller, Lyle Rossiter, Wayne Roush, Josh Sievers, Micah Smidt, and Matt Schnabel. On-Farm Soybean Fungicide Trials. Ames: Iowa State University, Digital Repository, 2015. http://dx.doi.org/10.31274/farmprogressreports-180814-1121.
Full textFawcett, Jim, Lance Miller, Lyle Rossiter, Wayne Roush, Josh Sievers, Micah Smidt, and Matt Schnabel. On-Farm Soybean Fungicide Trials. Ames: Iowa State University, Digital Repository, 2015. http://dx.doi.org/10.31274/farmprogressreports-180814-1212.
Full textFawcett, Jim, Zack Koopman, Wayne Roush, and Josh Sievers. On-Farm Corn Rootworm Trials. Ames: Iowa State University, Digital Repository, 2015. http://dx.doi.org/10.31274/farmprogressreports-180814-1261.
Full textFawcett, Jim, and Josh Sievers. On-Farm Corn Planter Trials. Ames: Iowa State University, Digital Repository, 2016. http://dx.doi.org/10.31274/farmprogressreports-180814-1408.
Full textFawcett, Jim, Josh Sievers, and Lyle Rossiter. On-Farm Cover Crop Trials. Ames: Iowa State University, Digital Repository, 2016. http://dx.doi.org/10.31274/farmprogressreports-180814-1469.
Full text